IdentificationGeneric Name(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanolDrugBank Accession NumberDB07750BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol (DB07750)× CloseWeightAverage: 448.346 Monoisotopic: 447.122880419 Chemical FormulaC21H23Cl2N5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCyclin-dependent kinase 2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as dichlorobenzenes. These are compounds containing a benzene with exactly two chlorine atoms attached to it.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassHalobenzenesDirect ParentDichlorobenzenesAlternative ParentsAniline and substituted anilines / Phenoxy compounds / Phenol ethers / Alkyl aryl ethers / Aminopyrimidines and derivatives / Aryl chlorides / Imidolactams / Heteroaromatic compounds / Trialkylamines / 1,2-aminoalcohols / Secondary alcohols / Azacyclic compounds / Secondary amines / Hydrocarbon derivatives / Organochlorides / Organopnictogen compounds


 show 6 moreSubstituents1,2-aminoalcohol / 1,4-dichlorobenzene / Alcohol / Alkyl aryl ether / Amine / Aminopyrimidine / Aniline or substituted anilines / Aromatic heteromonocyclic compound / Aryl chloride / Aryl halide / Azacycle / Ether / Heteroaromatic compound / Hydrocarbon derivative / Imidolactam / Organic nitrogen compound / Organic oxygen compound / Organochloride / Organohalogen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Phenol ether / Phenoxy compound / Pyrimidine / Secondary alcohol / Secondary amine / Tertiary aliphatic amine / Tertiary amine


 show 20 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal Descriptorsaminopyrimidine, dichlorobenzene (CHEBI:47405) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyGNLAGGCSJGJECE-MRXNPFEDSA-NInChIInChI=1S/C21H23Cl2N5O2/c1-28(2)12-16(29)13-30-17-6-4-15(5-7-17)25-21-24-10-9-20(27-21)26-19-11-14(22)3-8-18(19)23/h3-11,16,29H,12-13H2,1-2H3,(H2,24,25,26,27)/t16-/m1/s1IUPAC Name(2R)-1-[4-({4-[(2,5-dichlorophenyl)amino]pyrimidin-2-yl}amino)phenoxy]-3-(dimethylamino)propan-2-olSMILES[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound445952PubChem Substance99444221ChemSpider393432ZINCZINC000000602494PDBe LigandFALPDB Entries1h01Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.02 mg/mLALOGPSlogP4.38ALOGPSlogP4.64ChemaxonlogS-4.4ALOGPSpKa (Strongest Acidic)13.76ChemaxonpKa (Strongest Basic)8.7ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area82.54 Å2ChemaxonRotatable Bond Count9ChemaxonRefractivity120.01 m3·mol-1ChemaxonPolarizability47.26 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9689Blood Brain Barrier-0.5075Caco-2 permeable+0.522P-glycoprotein substrateSubstrate0.6666P-glycoprotein inhibitor INon-inhibitor0.7073P-glycoprotein inhibitor IIInhibitor0.9174Renal organic cation transporterNon-inhibitor0.7376CYP450 2C9 substrateNon-substrate0.823CYP450 2D6 substrateNon-substrate0.793CYP450 3A4 substrateSubstrate0.5622CYP450 1A2 substrateNon-inhibitor0.5124CYP450 2C9 inhibitorNon-inhibitor0.774CYP450 2D6 inhibitorNon-inhibitor0.5488CYP450 2C19 inhibitorNon-inhibitor0.6217CYP450 3A4 inhibitorNon-inhibitor0.6943CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5917Ames testNon AMES toxic0.6503CarcinogenicityNon-carcinogens0.8644BiodegradationNot ready biodegradable1.0Rat acute toxicity2.3546 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.74hERG inhibition (predictor II)Inhibitor0.5861  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Cyclin-dependent kinase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionMetal ion bindingSpecific FunctionSerine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N...Gene NameCDK2Uniprot IDP24941Uniprot NameCyclin-dependent kinase 2Molecular Weight33929.215 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 